A

Alibaba Health Information Technology Ltd
HKEX:241

Watchlist Manager
Alibaba Health Information Technology Ltd
HKEX:241
Watchlist
Price: 3.45 HKD -0.29% Market Closed
Market Cap: 55.5B HKD
Have any thoughts about
Alibaba Health Information Technology Ltd?
Write Note

Alibaba Health Information Technology Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Alibaba Health Information Technology Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
A
Alibaba Health Information Technology Ltd
HKEX:241
Total Equity
ÂĄ14.5B
CAGR 3-Years
1%
CAGR 5-Years
24%
CAGR 10-Years
27%
China Ruyi Holdings Ltd
HKEX:136
Total Equity
ÂĄ12.3B
CAGR 3-Years
83%
CAGR 5-Years
62%
CAGR 10-Years
N/A
Cybernaut International Holdings Co Ltd
HKEX:1020
Total Equity
ÂĄ112m
CAGR 3-Years
-27%
CAGR 5-Years
-26%
CAGR 10-Years
-15%
Y
YesAsia Holdings Ltd
HKEX:2209
Total Equity
$35.1m
CAGR 3-Years
16%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Hong Kong Technology Venture Co Ltd
HKEX:1137
Total Equity
HK$2.1B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Y
Yoho Group Holdings Ltd
HKEX:2347
Total Equity
HK$78.7m
CAGR 3-Years
0%
CAGR 5-Years
25%
CAGR 10-Years
N/A
No Stocks Found

Alibaba Health Information Technology Ltd
Glance View

Market Cap
55.4B HKD
Industry
Retail

Alibaba Health Information Technology Ltd., often referred to as Alibaba Health, is a pioneering force in the rapidly evolving realm of digital healthcare. As the healthcare arm of the Alibaba conglomerate, it capitalizes on the group's formidable tech expertise and e-commerce prowess to streamline health services. Its operations stretch across several domains, from pharmaceutical retail to medical services. One of the company's key strengths lies in its online pharmacy platform. Partnering with various pharmaceutical brands, Alibaba Health provides an extensive digital marketplace for medications, health supplements, and medical devices. This platform not only simplifies access for consumers but also integrates data analytics to manage supply chains efficiently, ensuring timely availability of products. Beyond its e-commerce foundation, Alibaba Health is also cultivating a robust digital health ecosystem. It offers telemedicine services where users can consult healthcare professionals via online platforms, a feature that gained significant traction during pandemic-related lockdowns. Moreover, the company dives deep into health management technologies, utilizing artificial intelligence to develop personalized health plans and digital tools for patient monitoring. By harnessing big data, Alibaba Health assists in forming public health decisions and improving patient outcomes. Revenues stream from not just product sales, but also subscription fees and partnerships with health providers and governments alike, positioning the company as a pivotal player in China's push towards a more integrated and efficient healthcare system.

Intrinsic Value
2.54 HKD
Overvaluation 26%
Intrinsic Value
Price
A

See Also

What is Alibaba Health Information Technology Ltd's Total Equity?
Total Equity
14.5B CNY

Based on the financial report for Sep 30, 2024, Alibaba Health Information Technology Ltd's Total Equity amounts to 14.5B CNY.

What is Alibaba Health Information Technology Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
27%

Over the last year, the Total Equity growth was -10%. The average annual Total Equity growth rates for Alibaba Health Information Technology Ltd have been 1% over the past three years , 24% over the past five years , and 27% over the past ten years .

Back to Top